NSE
Morepen Laboratories LimitedMOREPENLAB
Morepen Laboratories Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic drugs.
| Key products | Generic drugs |
|---|---|
| Geography | India, export to Southeast Asia, Middle East, Africa |
| Competitors | Dr Reddy's Laboratories, Cipla, Sun Pharmaceutical Industries |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹0.2 Cr
Institutional buyers
1 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹12.8 Cr | 131 | — | — | — | — |
| 2 | MOREPENLABThis | — | — | — | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 60 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | MTNL | — | — | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 6 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 4
- 5
No bulk/block deals for MOREPENLAB in this window.
Results & transcripts
Financial results
None yet.
Calls & transcripts
- Significant increase in volume has been observed in Morepen Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Morepen Laboratories Limited has submitted their response. (PDF) →
- Significant increase in volume has been observed in Morepen Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. (PDF) →
News & chatter on MOREPENLAB
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.